» Articles » PMID: 33809963

Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2

Abstract

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome corona virus-2 (SARS-CoV-2), is the most important health issue, internationally. With no specific and effective antiviral therapy for COVID-19, new or repurposed antiviral are urgently needed. Phytochemicals pose a ray of hope for human health during this pandemic, and a great deal of research is concentrated on it. Phytochemicals have been used as antiviral agents against several viruses since they could inhibit several viruses via different mechanisms of direct inhibition either at the viral entry point or the replication stages and via immunomodulation potentials. Recent evidence also suggests that some plants and its components have shown promising antiviral properties against SARS-CoV-2. This review summarizes certain phytochemical agents along with their mode of actions and potential antiviral activities against important viral pathogens. A special focus has been given on medicinal plants and their extracts as well as herbs which have shown promising results to combat SARS-CoV-2 infection and can be useful in treating patients with COVID-19 as alternatives for treatment under phytotherapy approaches during this devastating pandemic situation.

Citing Articles

Plant-Based Diet and Sports Performance.

Sarmento T, Ferreira R, Franco O ACS Omega. 2024; 9(49):47939-47950.

PMID: 39676988 PMC: 11635497. DOI: 10.1021/acsomega.4c07560.


A critical review on phytochemicals as antiviral medications for SARS-CoV-2 virus infection.

Das M, Panigrahy N Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39352534 DOI: 10.1007/s00210-024-03467-z.


Quest for Anti-SARS-CoV-2 antiviral therapeutics: in-silico and in-vitro analysis of edible mushroom- Cordyceps militaris.

Gandhale P, Chikhale R, Khanal P, Biswa V, Ali R, Khan M J Ayurveda Integr Med. 2024; 15(3):100979.

PMID: 38871595 PMC: 11282376. DOI: 10.1016/j.jaim.2024.100979.


Phytoconstituents of Artemisia Annua as potential inhibitors of SARS CoV2 main protease: an in silico study.

Irfan E, Dilshad E, Ahmad F, Almajhdi F, Hussain T, Abdi G BMC Infect Dis. 2024; 24(1):495.

PMID: 38750422 PMC: 11094927. DOI: 10.1186/s12879-024-09387-w.


Kaempferol: A Review of Current Evidence of Its Antiviral Potential.

Periferakis A, Periferakis A, Troumpata L, Periferakis K, Scheau A, Savulescu-Fiedler I Int J Mol Sci. 2023; 24(22).

PMID: 38003488 PMC: 10671393. DOI: 10.3390/ijms242216299.


References
1.
Sola I, Almazan F, Zuniga S, Enjuanes L . Continuous and Discontinuous RNA Synthesis in Coronaviruses. Annu Rev Virol. 2016; 2(1):265-88. PMC: 6025776. DOI: 10.1146/annurev-virology-100114-055218. View

2.
Ren G, Ding G, Zhang H, Wang H, Jin Z, Yang G . Antiviral activity of sophoridine against enterovirus 71 in vitro. J Ethnopharmacol. 2019; 236:124-128. DOI: 10.1016/j.jep.2019.02.045. View

3.
Zhang Y, Zhang Q, Li X, Xiong J, Xiao S, Wang Z . Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture. Emerg Microbes Infect. 2020; 9(1):1170-1173. PMC: 7448857. DOI: 10.1080/22221751.2020.1772676. View

4.
Russo M, Moccia S, Spagnuolo C, Tedesco I, Russo G . Roles of flavonoids against coronavirus infection. Chem Biol Interact. 2020; 328:109211. PMC: 7385538. DOI: 10.1016/j.cbi.2020.109211. View

5.
Chen H, Liu P, Zhang T, Gao Y, Zhang Y, Shen X . Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells. Oncol Rep. 2018; 39(3):921-928. PMC: 5802041. DOI: 10.3892/or.2018.6191. View